Log in

867 China Medical System Holdings Ltd. HKEX · China

China Medical System Holdings (867) news

China Medical System Holdings Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 867, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest China Medical System Holdings news

We have not published a story on China Medical System Holdings yet. When there is news, it will appear here.

Questions about China Medical System Holdings

What is the ticker symbol of China Medical System Holdings?

China Medical System Holdings Ltd. trades under the ticker 867 on HKEX.

Where is China Medical System Holdings listed?

China Medical System Holdings Ltd. is listed on HKEX. Our directory also records these other listings: GETTEX:2M7C; OTC:CHSYF; SGX:8A8.

Which country or territory is China Medical System Holdings listed under?

Our directory records China Medical System Holdings Ltd. under China.

What does China Medical System Holdings do?

Our directory classifies China Medical System Holdings Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of China Medical System Holdings?

The ISIN recorded for China Medical System Holdings Ltd. is KYG211081248.

Does aibio.space cover China Medical System Holdings?

aibio.space lists China Medical System Holdings Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to China Medical System Holdings?

Companies in our directory listed in the same country and business area as China Medical System Holdings: Jiuzhitang Co., Hybio Pharmaceutical Co., Northeast Pharmaceutical Group Co., Hunan Nucien Pharmaceutical Co., Everest Medicines, Yabao Pharmaceutical Group Co..

Investor discussion: China Medical System Holdings

Members talk about China Medical System Holdings (867). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Press releases

Headlines of China Medical System Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    CHANGE OF COMPANY NAME OF SINGAPORE SHARE TRANSFER AGENT

  2. HKEXnews

    Voluntary and Business Update Announcement Approval of Drug Clinical Trials for Systemic Lupus Erythematosus of Innovative Drug Highly Selective TYK2 Inhibitor CMS-D001

  3. HKEXnews

    Voluntary and Business Update Announcement New Drug Application for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Lumirix Approved in China

  4. HKEXnews

    LETTER TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY FORM

  5. HKEXnews

    LETTER TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY FORM

  6. HKEXnews

    (Revised) INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2026

  7. HKEXnews

    INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2026

  8. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  9. HKEXnews

    Voluntary and Business Update Announcement Approval of Drug Clinical Trials for Age-related Macular Degeneration Indication of Self-developed Innovative Drug Complement Factor B Inhibitor CMS-D017

  10. HKEXnews

    APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

  11. HKEXnews

    Voluntary and Business Update Announcement New Drug Application of Class 1 Innovative Drug Recombinant Fully Human Bispecific Antibody Against Rabies Virus Silevimig Injection Approved in China

  12. HKEXnews

    Voluntary and Business Update Announcement Approval of Drug Clinical Trials for Ulcerative Colitis and Crohn's Disease of Innovative Drug Highly Selective TYK2 Inhibitor CMS-D001

  13. HKEXnews

    ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 23 APRIL 2026

  14. HKEXnews

    Voluntary and Business Update Announcement New Drug Application for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China

  15. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  16. HKEXnews

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 AND CHANGE OF MEMBER OF THE ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE

  17. HKEXnews

    Terms of Reference of the Nomination Committee

  18. HKEXnews

    FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025

  19. HKEXnews

    Voluntary and Business Update Announcement New Drug for Renal Anaemia Desidustat Tablets Approved in China

  20. HKEXnews

    Voluntary and Business Update Announcement Approval of Drug Clinical Trials for Overweight/Obesity Indication of Self-Developed Innovative Drug INHBE-Targeting Small Nucleic Acid Drug CMS-D008

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:867 on TradingView.

Listing details

China Medical System Holdings Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 867, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
China Medical System Holdings Ltd.
Ticker
867
Listing
HKEX
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
KYG211081248
Other listed symbols
GETTEX:2M7C; OTC:CHSYF; SGX:8A8
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.